Mitochondrial Energetics in the Heart in Obesity-Related Diabetes
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
OBJECTIVE—In obesity and diabetes, myocardial fatty acid utilization and myocardial oxygen consumption (MVo2) are increased, and cardiac efficiency is reduced. Mitochondrial uncoupling has been proposed to contribute to these metabolic abnormalities but has not been directly demonstrated. RESEARCH DESIGN AND METHODS—Oxygen consumption and cardiac function were determined in db/db hearts perfused with glucose or glucose and palmitate. Mitochondrial function was determined in saponin-permeabilized fibers and proton leak kinetics and H2O2 generation determined in isolated mitochondria. RESULTS— db/db hearts exhibited reduced cardiac function and increased MVo2. Mitochondrial reactive oxygen species (ROS) generation and lipid and protein peroxidation products were increased. Mitochondrial proliferation was increased in db/db hearts, oxidative phosphorylation capacity was impaired, but H2O2 production was increased. Mitochondria from db/db mice exhibited fatty acid–induced mitochondrial uncoupling that is inhibitable by GDP, suggesting that these changes are mediated by uncoupling proteins (UCPs). Mitochondrial uncoupling was not associated with an increase in UCP content, but fatty acid oxidation genes and expression of electron transfer flavoproteins were increased, whereas the content of the F1 α-subunit of ATP synthase was reduced. CONCLUSIONS—These data demonstrate that mitochondrial uncoupling in the heart in obesity and diabetes is mediated by activation of UCPs independently of changes in expression levels. This likely occurs on the basis of increased delivery of reducing equivalents from β-oxidation to the electron transport chain, which coupled with decreased oxidative phosphorylation capacity increases ROS production and lipid peroxidation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Animal studies also support a role for T2D in altering myocardial mitochondrial function, such as decreased maximal mitochondrial ATP production despite increased mitochondrial biogenesis, altered palmitate and glucose oxidation, increased ROS emission, and increased mitochondrial uncoupling (117, 118).”
From Altered mitochondrial function in insulin-deficient and insulin-resistant states (2018) · cites this paper as [117]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“A commonly described feature of most animal models of obesity is increased accumulation of intramyocellular triglycerides in the heart. This has been reported in the hearts of genetic models such as ob/ob and db/db mice (29, 31, 34, 53), Zucker or fa/fa rats (394), and following high-fat feeding (346).”
From Cardiac remodeling in obesity (2008) · cites this paper as [31]
Experimental — accuracy not yet measuredIn the citing paper
“Mitochondrial protein also can be evaluated for 4-HNE protein adducts with immunoblotting antibody (34), although specificity can be questioned.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [34]
In the citing paper
“Boudina et al. (34) reported an increase in ROS production, a decrease in ATP production, and an increase in a marker of oxidative damage (4-HNE) in heart mitochondria of insulin-resistant, obese, and leptin receptor–deficient db/db mice, a model of extreme obesity associated with diabetes.”
From Mitochondrial Dysfunction in Diabetes: From Molecular Mechanisms to Functional Significance and Therapeutic Opportunities (2010) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
St-Pierre, J., Drori, S., Uldry, M., Silvaggi, J. M., Rhee, J., Jäger, S., Handschin, C., Zheng, K., Lin, J., Yang, W., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.024 · Cited by 2,233
Thermogenic mechanisms in brown fat.
Nicholls, D. G., & Locke, R. M. (1984) · Physiological Reviews · doi:10.1152/physrev.1984.64.1.1 · Cited by 1,602 · cited 1×
“UCP1-mediated uncoupling of brown adipose tissue is well accepted (13).”
BackgroundDiabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Self-citationSuperoxide activates mitochondrial uncoupling proteins
Echtay, K. S., Roussel, D., St-Pierre, J., Jekabsons, M. B., Cadenas, S., Stuart, J. A., Harper, J. A., Roebuck, S. J., Morrison, A., Pickering, S., et al. (2002) · Nature · doi:10.1038/415096a · Cited by 1,382
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Mitochondrial superoxide: production, biological effects, and activation of uncoupling proteins
Brand, M. D., Affourtit, C., Esteves, T. C., Green, K., Lambert, A. J., Miwa, S., Pakay, J. L., & Parker, N. (2004) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2004.05.034 · Cited by 1,032
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovács, A. D., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14080 · Cited by 879
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
Finck, B. N., Lehman, J. J., Leone, T. C., Welch, M. J., Bennett, M. J., Kovacs, A., Han, X., Gross, R. W., Kozak, R., Lopaschuk, G. D., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214080 · Cited by 763
A role for uncoupling protein‐2 as a regulator of mitochondrial hydrogen peroxide generation
Nègre‐Salvayre, A., Hirtz, C., Carrera, G., Cazenave, R., Troly, M., Salvayre, R., Pénicaud, L., & Casteilla, L. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.10.9271366 · Cited by 760
Peterson, L. R., Herrero, P., Schechtman, K. B., Racette, S. B., Waggoner, A. D., Kisrieva-Ware, Z., Dence, C., Klein, S., Marsala, J., Meyer, T., et al. (2004) · Circulation · doi:10.1161/01.cir.0000127959.28627.f8 · Cited by 656
Cited by
Myocardial Fatty Acid Metabolism in Health and Disease
Lopaschuk, G. D., Ussher, J. R., Folmes, C. D. L., Jaswal, J. S., & Stanley, W. C. (2010) · Physiological Reviews · doi:10.1152/physrev.00015.2009 · Cited by 2,179
Cardiac Energy Metabolism in Heart Failure
Lopaschuk, G. D., Karwi, Q. G., Tian, R., Wende, A. R., & Abel, E. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318241 · Cited by 1,373
Self-citationLubos, E., Loscalzo, J., & Handy, D. E. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3586 · Cited by 1,280
Mitochondrial dysfunction in pathophysiology of heart failure
Zhou, B., & Tian, R. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120849 · Cited by 923
Molecular mechanisms of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2014) · Diabetologia · doi:10.1007/s00125-014-3171-6 · Cited by 903
Self-citationGreen, C. B., Takahashi, J. S., & Bass, J. (2008) · Cell · doi:10.1016/j.cell.2008.08.022 · Cited by 902
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Cardiac Metabolism and its Interactions With Contraction, Growth, and Survival of Cardiomyocytes
Kolwicz, S. C., Purohit, S., & Tian, R. (2013) · Circulation Research · doi:10.1161/circresaha.113.302095 · Cited by 813
Sivitz, W. I., & Yorek, M. A. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2531 · Cited by 742
Abel, E. D., Litwin, S. E., & Sweeney, G. (2008) · Physiological Reviews · doi:10.1152/physrev.00017.2007 · Cited by 736
Self-citationDiabetic cardiomyopathy, causes and effects
Boudina, S., & Abel, E. D. (2010) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-010-9131-7 · Cited by 728
Self-citationBasic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Self-citationKenny, H. C., & Abel, E. D. (2019) · Circulation Research · doi:10.1161/circresaha.118.311371 · Cited by 660
Self-citationMolecular and Cellular Mechanisms of Cardiovascular Disorders in Diabetes
Shah, M. S., & Brownlee, M. (2016) · Circulation Research · doi:10.1161/circresaha.116.306923 · Cited by 602
Molecular mechanism of doxorubicin-induced cardiomyopathy – An update
Renu, K., V.G., A., P.B., T. P., & Arunachalam, S. (2018) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.10.043 · Cited by 588
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Russo, I., & Frangogiannis, N. G. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.011 · Cited by 474
Anderson, E. J., Kypson, A. P., Rodriguez, E., Anderson, C. A., Lehr, E. J., & Neufer, P. D. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.07.031 · Cited by 440
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Cheng, C.-F., Ku, H.-C., & Lin, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113447 · Cited by 437
Mitochondrial dysfunction in type 2 diabetes mellitus: an organ-based analysis
Pinti, M. V., Fink, G. K., Hathaway, Q. A., Durr, A. J., Kunovac, A., & Hollander, J. M. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00314.2018 · Cited by 427
Effects and Mechanisms of Taurine as a Therapeutic Agent
Schaffer, S., & Kim, H. W. (2018) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2017.251 · Cited by 414
Insulin Signaling and Heart Failure
Riehle, C., & Abel, E. D. (2016) · Circulation Research · doi:10.1161/circresaha.116.306206 · Cited by 418
Self-citationJaswal, J. S., Keung, W., Wang, W., Ussher, J. R., & Lopaschuk, G. D. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.015 · Cited by 400
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Anderson, N., & Borlak, J. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.00001 · Cited by 385
Bray, M. S., Shaw, C. A., Moore, M. W. S., Garcia, R. A. P., Zanquetta, M. M., Durgan, D. J., Jeong, W. J., Tsai, J.-Y., Bugger, H., Zhang, D., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01291.2007 · Cited by 384
Self-citationOxidative stress and calcium dysregulation by palmitate in type 2 diabetes
Ly, L. D., Xu, S., Choi, S.-K., Ha, C.-M., Thoudam, T., Cha, S.-K., Wiederkehr, A., Wollheim, C. B., Lee, I.-K., & Park, K.-S. (2017) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.157 · Cited by 378
Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications
Ren, J., Wu, N. N., Wang, S., Sowers, J. R., & Zhang, Y. (2021) · Physiological Reviews · doi:10.1152/physrev.00030.2020 · Cited by 370
PGC-1 Coactivators in Cardiac Development and Disease
Rowe, G. C., Jiang, A., & Arany, Z. (2010) · Circulation Research · doi:10.1161/circresaha.110.223818 · Cited by 355
Oxidative Stress and Cardiovascular Risk: Obesity, Diabetes, Smoking, and Pollution
Niemann, B., Rohrbach, S., Miller, M. R., Newby, D. E., Fuster, V., & Kovacic, J. C. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.05.043 · Cited by 353
Wende, A. R., & Abel, E. D. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.023 · Cited by 343
Self-citationThe renin-angiotensin system: going beyond the classical paradigms
Santos, R. A. S., Oudit, G. Y., Verano-Braga, T., Canta, G., Steckelings, U. M., & Bader, M. (2019) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00723.2018 · Cited by 340
Tsushima, K., Bugger, H., Wende, A. R., Soto, J., Jenson, G. A., Tor, A. R., McGlauflin, R., Kenny, H. C., Zhang, Y., Souvenir, R., et al. (2018) · Circulation Research · doi:10.1161/circresaha.117.311307 · Cited by 330
Self-citationMitochondrial reactive oxygen species production and elimination
Nickel, A., Kohlhaas, M., & Maack, C. (2014) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2014.03.011 · Cited by 317
Boudina, S., Bugger, H., Sena, S., O'Neill, B. T., Zaha, V. G., Ilkun, O., Wright, J. J., Mazumder, P. K., Palfreyman, E., Tidwell, T. J., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.792101 · Cited by 301
Self-citationCardiolipin Remodeling by ALCAT1 Links Oxidative Stress and Mitochondrial Dysfunction to Obesity
Li, J., Romestaing, C., Han, X., Li, Y., Hao, X., Wu, Y., Sun, C., Liu, X., Jefferson, L. S., Xiong, J., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.07.003 · Cited by 295
Ni, R., Cao, T., Xiong, S., Ma, J., Fan, G.-C., Lacefield, J. C., Lu, Y., Tissier, S. L., & Peng, T. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.11.013 · Cited by 288
Rodent models of diabetic cardiomyopathy
Bugger, H., & Abel, E. D. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001941 · Cited by 285
Self-citationCavalera, M., Wang, J., & Frangogiannis, N. G. (2014) · Translational Research · doi:10.1016/j.trsl.2014.05.001 · Cited by 267
Mitochondrial ROS Formation in the Pathogenesis of Diabetic Cardiomyopathy
Kaludercic, N., & Di Lisa, F. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00012 · Cited by 263
Mitochondrial and cellular mechanisms for managing lipid excess
Aon, M. A., Bhatt, N., & Cortassa, S. C. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00282 · Cited by 253
Mitochondria in the diabetic heart
Bugger, H., & Abel, E. D. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq239 · Cited by 260
Self-citationPatel, V. B., Mori, J., McLean, B. A., Basu, R., Das, S. K., Ramprasath, T., Parajuli, N., Penninger, J. M., Grant, M. B., Lopaschuk, G. D., et al. (2016) · Diabetes · doi:10.2337/db15-0399 · Cited by 255
Lipotoxicity in type 2 diabetic cardiomyopathy
van de Weijer, T., Schrauwen-Hinderling, V. B., & Schrauwen, P. (2011) · Cardiovascular Research · doi:10.1093/cvr/cvr212 · Cited by 235
Yang, J., Chi, Y., Burkhardt, B. R., Guan, Y., & Wolf, B. A. (2010) · Nutrition Reviews · doi:10.1111/j.1753-4887.2010.00282.x · Cited by 235
OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance
Pereira, R. O., Tadinada, S. M., Zasadny, F. M., Oliveira, K. J., Pires, K. M. P., Olvera, A., Jeffers, J., Souvenir, R., Mcglauflin, R., Seei, A., et al. (2017) · The EMBO Journal · doi:10.15252/embj.201696179 · Cited by 211
Self-citationParra, V., Verdejo, H. E., Iglewski, M., del Campo, A., Troncoso, R., Jones, D., Zhu, Y., Kuzmicic, J., Pennanen, C., Lopez‑Crisosto, C., et al. (2014) · Diabetes · doi:10.2337/db13-0340 · Cited by 218
Self-citationShao, D., Kolwicz, S. C., Wang, P., Roe, N. D., Villet, O., Nishi, K., Hsu, Y.-W. A., Flint, G. V., Caudal, A., Wang, W., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.043319 · Cited by 217
Insulin-Like Growth Factor I Receptor Signaling Is Required for Exercise-Induced Cardiac Hypertrophy
Kim, J., Wende, A. R., Sena, S., Theobald, H. A., Soto, J., Sloan, C., Wayment, B. E., Litwin, S. E., Holzenberger, M., LeRoith, D., et al. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0265 · Cited by 215
Self-citationMitochondrial dysfunction in diabetic cardiomyopathy
Duncan, J. G. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.01.014 · Cited by 208
Altered mitochondrial function in insulin-deficient and insulin-resistant states
Ruegsegger, G. N., Creo, A. L., Cortes, T. M., Dasari, S., & Nair, K. S. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120843 · Cited by 202
SIRT3 deficiency impairs mitochondrial and contractile function in the heart
Koentges, C., Pfeil, K., Schnick, T., Wiese, S., Dahlbock, R., Cimolai, M. C., Meyer-Steenbuck, M., Cenkerova, K., Hoffmann, M. M., Jaeger, C., et al. (2015) · Basic Research in Cardiology · doi:10.1007/s00395-015-0493-6 · Cited by 200
Self-citationMolecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome
Bugger, H., & Dale Abel, E. (2008) · Clinical Science · doi:10.1042/cs20070166 · Cited by 198
Self-citationOf mice and men: models and mechanisms of diabetic cardiomyopathy
Riehle, C., & Bauersachs, J. (2019) · Basic Research in Cardiology · doi:10.1007/s00395-018-0711-0 · Cited by 196
Targeting cardiac fibrosis in heart failure with preserved ejection fraction: mirage or miracle?
Sweeney, M., Corden, B., & Cook, S. A. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201910865 · Cited by 195
Potential Therapeutic Benefits of Strategies Directed to Mitochondria
Camara, A. K. S., Lesnefsky, E. J., & Stowe, D. F. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2788 · Cited by 194
Molecular and metabolic mechanisms of cardiac dysfunction in diabetes
Mandavia, C. H., Aroor, A. R., DeMarco, V. G., & Sowers, J. R. (2013) · Life Sciences · doi:10.1016/j.lfs.2012.10.028 · Cited by 190
Cole, M. A., Murray, A. J., Cochlin, L. E., Heather, L. C., McAleese, S., Knight, N. S., Sutton, E., Jamil, A. A., Parassol, N., & Clarke, K. (2011) · Basic Research in Cardiology · doi:10.1007/s00395-011-0156-1 · Cited by 189
Uthman, L., Baartscheer, A., Schumacher, C. A., Fiolet, J. W. T., Kuschma, M. C., Hollmann, M. W., Coronel, R., Weber, N. C., & Zuurbier, C. J. (2018) · Frontiers in Physiology · doi:10.3389/fphys.2018.01575 · Cited by 188
Rac1 Is Required for Cardiomyocyte Apoptosis During Hyperglycemia
Shen, E., Li, Y., Li, Y., Shan, L., Zhu, H., Feng, Q., Arnold, J. M. O., & Peng, T. (2009) · Diabetes · doi:10.2337/db08-0617 · Cited by 185
Bugger, H., Boudina, S., Hu, X. X., Tuinei, J., Zaha, V. G., Theobald, H. A., Yun, U. J., McQueen, A. P., Wayment, B., Litwin, S. E., et al. (2008) · Diabetes · doi:10.2337/db08-0079 · Cited by 182
Self-citationTissue-Specific Remodeling of the Mitochondrial Proteome in Type 1 Diabetic Akita Mice
Bugger, H., Chen, D., Riehle, C., Soto, J., Theobald, H. A., Hu, X. X., Ganesan, B., Weimer, B. C., & Abel, E. D. (2009) · Diabetes · doi:10.2337/db09-0259 · Cited by 180
Self-citationPenna, C., Perrelli, M.-G., & Pagliaro, P. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4459 · Cited by 179
Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
Byrne, N. J., Rajasekaran, N. S., Abel, E. D., & Bugger, H. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.03.046 · Cited by 174
Self-citationYan, W., Zhang, H., Liu, P., Wang, H., Liu, J., Gao, C., Liu, Y., Lian, K., Yang, L., Sun, L., et al. (2013) · Basic Research in Cardiology · doi:10.1007/s00395-013-0329-1 · Cited by 169
Mechanisms for increased myocardial fatty acid utilization following short-term high-fat feeding
Wright, J. J., Kim, J., Buchanan, J., Boudina, S., Sena, S., Bakirtzi, K., Ilkun, O., Theobald, H. A., Cooksey, R. C., Kandror, K. V., et al. (2009) · Cardiovascular Research · doi:10.1093/cvr/cvp017 · Cited by 173
Self-citationRole of Leptin in Cardiovascular Diseases
Poetsch, M. S., Strano, A., & Guan, K. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00354 · Cited by 171
Epidemiology, Pathophysiology, Diagnosis and Treatment of Heart Failure in Diabetes
Park, J. J. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0282 · Cited by 171
Chattopadhyay, M., Khemka, V. K., Chatterjee, G., Ganguly, A., Mukhopadhyay, S., & Chakrabarti, S. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-014-2236-7 · Cited by 172
Diakos, N. A., Navankasattusas, S., Abel, E. D., Rutter, J., McCreath, L., Ferrin, P., McKellar, S. H., Miller, D. V., Park, S. Y., Richardson, R. S., et al. (2016) · JACC: Basic to Translational Science · doi:10.1016/j.jacbts.2016.06.009 · Cited by 166
Self-citationMitochondrial NAD + /NADH Redox State and Diabetic Cardiomyopathy
Berthiaume, J. M., Kurdys, J. G., Muntean, D. M., & Rosca, M. G. (2019) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7415 · Cited by 168
Mizuno, M., Kuno, A., Yano, T., Miki, T., Oshima, H., Sato, T., Nakata, K., Kimura, Y., Tanno, M., & Miura, T. (2018) · Physiological Reports · doi:10.14814/phy2.13741 · Cited by 169
Alterations of Mitochondrial Function and Insulin Sensitivity in Human Obesity and Diabetes Mellitus
Koliaki, C., & Roden, M. (2016) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071715-050656 · Cited by 165
Dabkowski, E. R., Baseler, W. A., Williamson, C. L., Powell, M., Razunguzwa, T. T., Frisbee, J. C., & Hollander, J. M. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00267.2010 · Cited by 165
Holloway, C. J., Cochlin, L. E., Emmanuel, Y., Murray, A., Codreanu, I., Edwards, L. M., Szmigielski, C., Tyler, D. J., Knight, N. S., Saxby, B. K., et al. (2011) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.002758 · Cited by 165
Rasmussen, T. P., Wu, Y., Joiner, M.-L. A., Koval, O. M., Wilson, N. R., Luczak, E. D., Wang, Q., Chen, B., Gao, Z., Zhu, Z., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504705112 · Cited by 162
Self-citationSon, N.-H., Yu, S., Tuinei, J., Arai, K., Hamai, H., Homma, S., Shulman, G. I., Abel, E. D., & Goldberg, I. J. (2010) · Journal of Clinical Investigation · doi:10.1172/jci40905 · Cited by 159
Self-citationLehman, J. J., Boudina, S., Banke, N. H., Sambandam, N., Han, X., Young, D. M., Leone, T. C., Gross, R. W., Lewandowski, E. D., Abel, E. D., et al. (2008) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00081.2008 · Cited by 158
Mitochondrial Mechanisms in Septic Cardiomyopathy
Cimolai, M. C., Álvarez, S., Bode, C., & Bugger, H. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms160817763 · Cited by 159
Self-citationPGC-1β Deficiency Accelerates the Transition to Heart Failure in Pressure Overload Hypertrophy
Riehle, C., Wende, A. R., Zaha, V. G., Pires, K. M. P., Wayment, B. E., Olsen, C. D., Bugger, H., Buchanan, J., Wang, X., Moreira, A. B., et al. (2011) · Circulation Research · doi:10.1161/circresaha.111.243964 · Cited by 158
Self-citationKLF5 Is Induced by FOXO1 and Causes Oxidative Stress and Diabetic Cardiomyopathy
Kyriazis, I. D., Hoffman, M., Gaignebet, L., Lucchese, A. M., Markopoulou, E., Palioura, D., Wang, C., Bannister, T. D., Christofidou‐Solomidou, M., Oka, S., et al. (2020) · Circulation Research · doi:10.1161/circresaha.120.316738 · Cited by 158
Effects of Catecholamine Stress on Diastolic Function and Myocardial Energetics in Obesity
Rider, O. J., Francis, J. M., Ali, M. K., Holloway, C. J., Pegg, T. J., Robson, M. D., Tyler, D. J., Byrne, J. P., Clarke, K., & Neubauer, S. (2012) · Circulation · doi:10.1161/circulationaha.111.069518 · Cited by 147
Ni, R., Zheng, D., Xiong, S., Hill, D. J., Sun, T., Gardiner, R. B., Fan, G., Lu, Y., Abel, E. D., Greer, P. A., et al. (2015) · Diabetes · doi:10.2337/db15-0963 · Cited by 150
Self-citationNew insights into insulin resistance in the diabetic heart
Gray, S., & Kim, J. K. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.05.001 · Cited by 164
Manifestations and mechanisms of myocardial lipotoxicity in obesity
Sletten, A. C., Peterson, L. R., & Schaffer, J. E. (2018) · Journal of Internal Medicine · doi:10.1111/joim.12728 · Cited by 159
HIF-1, Metabolism, and Diabetes in the Embryonic and Adult Heart
Čerychová, R., & Pavlínková, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00460 · Cited by 142
Mitochondrial Morphology in Metabolic Diseases
Galloway, C. A., & Yoon, Y. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4779 · Cited by 156
Vercesi, A. E., Castilho, R. F., Kowaltowski, A. J., Oliveira, H. C. F., de Souza-Pinto, N. C., Figueira, T. R., & Busanello, E. N. B. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.08.034 · Cited by 152
Ghesmati, Z., Rashid, M., Fayezi, S., Gieseler, F., Alizadeh, E., & Darabi, M. (2024) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09850-0 · Cited by 139
Murray, A. J., Knight, N. S., Cochlin, L. E., McAleese, S., Deacon, R. M. J., Rawlins, J. N. P., & Clarke, K. (2009) · The FASEB Journal · doi:10.1096/fj.09-139691 · Cited by 159
O'Neill, B. T., Kim, J., Wende, A. R., Theobald, H. A., Tuinei, J., Buchanan, J., Guo, A., Zaha, V. G., Davis, D. K., Schell, J. C., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.09.001 · Cited by 143
Self-citationMitochondrial Function and Dysfunction in Dilated Cardiomyopathy
Ramaccini, D., Montoya-Uribe, V., Aan, F. J., Modesti, L., Potes, Y., Wieckowski, M. R., Krga, I., Glibetić, M., Pinton, P., Giorgi, C., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.624216 · Cited by 136
Ilkun, O. L., & Boudina, S. (2013) · Current Pharmaceutical Design · doi:10.2174/1381612811319270003 · Cited by 147
Self-citationCardiac fatty acid oxidation in heart failure associated with obesity and diabetes
Fukushima, A., & Lopaschuk, G. D. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.03.020 · Cited by 152
Mitochondrial Dynamics in Diabetic Cardiomyopathy
Galloway, C. A., & Yoon, Y. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6293 · Cited by 139
Mitochondrial Mechanisms in Diabetic Cardiomyopathy
Gollmer, J., Zirlik, A., & Bugger, H. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0185 · Cited by 144
Self-citationTuleta, I., & Frangogiannis, N. G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113904 · Cited by 150
Metabolism, hypoxia and the diabetic heart
Heather, L. C., & Clarke, K. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2011.01.007 · Cited by 141
Sverdlov, A. L., Elezaby, A., Qin, F., Behring, J. B., Luptak, I., Calamaras, T. D., Siwik, D. A., Miller, E. J., Liesa, M., Shirihai, O. S., et al. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002555 · Cited by 137
Edwards, L. M., Murray, A. J., Holloway, C. J., Carter, E. E., Kemp, G. J., Codreanu, I., Brooker, H. J., Tyler, D. J., Robbins, P. A., & Clarke, K. (2010) · The FASEB Journal · doi:10.1096/fj.10-171983 · Cited by 135
DNA-PK Promotes the Mitochondrial, Metabolic, and Physical Decline that Occurs During Aging
Park, S. J., Gavrilova, O., Brown, A. L., Soto, J. E., Bremner, S. N., Kim, J., Xu, X., Yang, S., Um, J.-H., Koch, L. G., et al. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.04.008 · Cited by 130
Self-citation
Metadata
- Authors
- Boudina, S., Sena, S., Theobald, H., Sheng, X., Wright, J. J., Hu, X. X., Aziz, S., Johnson, J. I., Bugger, H., Zaha, V. G., & Abel, E. D.
- Affiliations
- University of Utah (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2007-10-01
- Volume
- 56
- Issue
- 10
- Pages
- 2457-2466
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2411240035
- Cited by
- 586
- References
- 52
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 15 · 2023: 27 · 2022: 30 · 2021: 34 · 2020: 31 · 2019: 34 · 2018: 39 · 2017: 28 · 2016: 34 · 2015: 43 · 2014: 46 · 2013: 33 · 2012: 35
- FWCI
- 9.44
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Heart Association
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL073167, UO1HL70525, U01HL070525)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Ischemia and Reperfusion
- Keywords
- mitochondrial uncoupling, obesity-related diabetes, db/db mice, myocardial oxygen consumption, fatty acid oxidation, uncoupling proteins, reactive oxygen species, lipid peroxidation, oxidative phosphorylation, electron transfer flavoprotein, proton leak, cardiac function, myocardial energy metabolism
- MeSH terms
- Animals, DNA, Mitochondrial, Heart Ventricles, Hydrogen Peroxide, Malondialdehyde, Mice, Mutant Strains, Microscopy, Electron, Mitochondria, Heart, Obesity, Oxygen Consumption, Reactive Oxygen Species, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.